HepPar-1 Expression in Primary Lung Adenocarcinoma

    loading  Checking for direct PDF access through Ovid



To study a subset of lung adenocarcinomas with aberrant HepPar-1 antigen expression.


We performed a clinicopathologic review of 16 cases.


Of 241 primary lung adenocarcinomas tested for expression of the HepPar-1 antigen, 16 (6.6%) were positive. The cases occurred in older smokers with an equal sex distribution. Morphologically, these pulmonary adenocarcinomas had an acinar-predominant architecture, and prominent cribriform growth, with HepPar-1–expressing tumor cells being uniformly columnar with abundant bipolar lightly eosinophilic cytoplasm. HepPar-1 was coexpressed with thyroid transcription factor 1 in 94% of cases. No EGFR mutations were identified, while 31% of cases were positive for KRAS codon 12 mutations.


Although aberrant HepPar-1 expression was frequently seen in tumors with visceral pleural and angiolymphatic invasion, its prognostic significance is uncertain.

Related Topics

    loading  Loading Related Articles